Abstract
Backgroud and Objective To predict the epidemic of COVID-19 based on quarantined surveillance from real world in China by modified SEIR model different from the previous simply mathematical model.
Design and Methods We forecasted the epidemic of COVID-19 based on current clinical and epidemiological data and built a modified SEIR model to consider both the infectivity during incubation period and the influence on the epidemic from strict quarantined measures.
Results The peak time of the curve for the infected newly diagnosed as COVID-19 should substantially present on Feb. 5, 2020 (in non-Hubei areas) and Feb. 19, 2020 (in Hubei). It is estimated that the peak of the curve of the cumulative confirmed cases will appear in non-Hubei areas on Mar. 3, 2020 and in Hubei province on Mar. 10, 2020, and the total number of the patients diagnosed as COVID-19 is 18,000 in non-Hubei areas and 78,000-96,000 in Hubei. The Chinese COVID-19 epidemic can be completetly controlled in May, 2020.
Conclusions COVID-19 is only a local outbreak in Hubei Province, China. It can be probably avoided the pandemic of global SARS-CoV-2 cases rise with the great efforts by Chinese government and its people.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There is no financial support.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
1)National Health Commission of People’s Republic of China(www.nhc.gov.cn) 2)Tencent's big data(https://heat.qq.com/)and Location Intelligence(www.wayhe.com) 3)Hubei Provincial Center for Disease Control and Prevention (http://wjw.hubei.gov.cn/)
